Mineralys Therapeutics, Inc. (MLYS)
Market Open
1 Sep, 18:41
NASDAQ (NGS) NASDAQ (NGS) Primary $
25. 13
-0.54
-2.1036%
$
2.26B Market Cap
- P/E Ratio
- Div Yield
300,496 Volume
-2.58 Eps
$ 25.67
Previous Close 
Want to track MLYS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mineralys Therapeutics, Inc. (MLYS) Statistics
Valuation metrics
Market Cap 2.26B
Enterprise value 2.22B
Trailing P/E (ttm) -6.04
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) -
Price/Book (mrq) 3.94
Enterprise Value/Revenue -
Enterprise Value/EBITDA -6.34
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 812.83K
Average volume (90 days) 1.6M
Price summary
52-Week low 22
52-Week high 47.65
Beta -
50-Day moving average 26.05
200-Day moving average 27.56
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.52%
Return on equity -0.58%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.81
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 34.46%
Book value per share (mrq) 6.5
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
